Originally Posted by
trader_jackson
I see, well (personally) I am willing to give him a few more years, I mean they are only just beginning the commercialization progress (I think) although his comments that they will have $100m in revenue in 5 years may come to bite him, but lets just wait and see, after all that's all we really can do.
Has anyone considered that the underwriters may just happen to think PEB is in a very good position and will do well? hence happy to underwrite it? (I'm sure First NZ understood the risks with underwriting a rather large amount of cash, for little return/fee to a speculative bio-tech company... to me this is the only logical reason left, [eliminating the reasoning they know something we don't])
On another note, after heavy trading, shares were on the way up today...